Achieve Life Sciences, Inc. (ACHV) Stock Analysis
DELISTED
What happened to Achieve Life Sciences, Inc. (ACHV) stock?
Achieve Life Sciences, Inc. (ACHV) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $698M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Achieve Life Sciences, Inc. (ACHV). Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company focused on developing and commercializing cytisinicline for smoking cessation and nicotine addiction. Their primary product, cytisinicline, is a plant-based alkaloid aimed at reducing nicotine withdrawal symptoms.
Last analyzed: May 9, 2026Achieve Life Sciences, Inc. (ACHV) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ACHV shares?
No. ACHV stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ACHV elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ACHV stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Achieve Life Sciences, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.